Science News
from research organizations

Add bone deterioration to diabetes complications

Date:
November 12, 2013
Source:
Mayo Clinic
Summary:
The list of complications from type 2 diabetes is long: vascular and heart disease, eye problems, nerve damage, kidney disease, hearing problems and Alzheimer’s disease. Physicians have long thought of osteoporosis as another outcome. Based on a study that’s confirmed: You can definitely add skeletal problems to that list.
Share:
       
FULL STORY

The list of complications from type 2 diabetes is long: vascular and heart disease, eye problems, nerve damage, kidney disease, hearing problems and Alzheimer’s disease. Physicians have long thought of osteoporosis as another outcome. Based on a Mayo Clinic study published in the Journal of Bone and Mineral Research, that’s confirmed: You can definitely add skeletal problems to that list.

“This is the first demonstration -- using direct measurement of bone strength in the body -- of compromised bone material in patients with type 2 diabetes,” says Sundeep Khosla, M.D., Mayo Clinic endocrinologist and senior author of the study. “Clearly, the skeleton needs to be recognized as another important target of diabetes complications.”

Previous studies in the field showed that patients with diabetes experienced fractures at levels of bone density above that of the regular population, hinting that something was different about the “quality” of their bone. The Mayo researchers validated that assumption in a clinical study of 60 postmenopausal women, 30 of whom had type 2 diabetes. Using a new tool (OsteoProbe®), the researchers performed micro indentation testing of the tibia (actually causing a microscopic crack) to measure bone material strength. Compared to the control group of women, aged 50 to 80, the group with type 2 diabetes had significantly lower bone material strength. There was no difference between the microarchitecture of the bone or bone density between the two groups. The study showed that diabetic women with lower bone material strength had also experienced higher levels of hyperglycemia over the previous 10 years, suggesting potential detrimental effects of poor glucose control on bone quality.

The resounding message: Conventional measurements underestimated the risk of fracture among patients with type 2 diabetes and loss of bone material strength, or bone quality, is a clear, downstream consequence of the disease. The new technology may help in studying other conditions where fractures occur at higher than expected bone density, says co-author and rheumatologist Shreyasee Amin, M.D. She says this will be especially relevant to many forms of autoimmune arthritis where glucocorticoids are used, such as in rheumatoid arthritis. The team says more research needs to be done, as this was a small study in a limited population.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Journal Reference:

  1. Joshua N. Farr, Matthew T. Drake, Shreyasee Amin, L. Joseph Melton, Louise K. McCready, Sundeep Khosla. In Vivoassessment of bone quality in postmenopausal women with type 2 diabetes. Journal of Bone and Mineral Research, 2013; DOI: 10.1002/jbmr.2106

Cite This Page:

Mayo Clinic. "Add bone deterioration to diabetes complications." ScienceDaily. ScienceDaily, 12 November 2013. <www.sciencedaily.com/releases/2013/11/131112141236.htm>.
Mayo Clinic. (2013, November 12). Add bone deterioration to diabetes complications. ScienceDaily. Retrieved May 25, 2015 from www.sciencedaily.com/releases/2013/11/131112141236.htm
Mayo Clinic. "Add bone deterioration to diabetes complications." ScienceDaily. www.sciencedaily.com/releases/2013/11/131112141236.htm (accessed May 25, 2015).

Share This Page: